AMAN Stock Forecast: Amanat Acquisition Corp. Price Predictions for 2026-2027
Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 6 of 100 as at 1 Aug 2026 — in the weakest quartile.
AMAN stock analysis: one number for the whole business
Consensus tells you what everyone already believes. The model scores Amanat Acquisition Corp. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Size (75): Smaller than most of the companies we track.
Issuance (1): The company has been issuing shares or taking on financing, diluting existing holders.
The rank is the raw material. Whether the rules would actually own Amanat Acquisition Corp. — and when they’d sell — is the membership.
AMAN stock forecast 2026-2027: analyst price targets & predictions
The bullish and bearish analyst opinions on AMAN, reported as data — targets and ratings, the market's view beside the model's.
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
AMAN analyst estimate revisions
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
Amanat Acquisition Corp. (AMAN) financial data
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
- Trailing P/E
- —
- Price / sales
- —
- Price / book
- −2912.6×
- EV / EBITDA
- —
Cheaper than 99% of US stocks
- Revenue growth (YoY)
- —
- Earnings growth (YoY)
- —
- Gross margin
- —
- Operating margin
- 0.0%
- Net margin
- 0.0%
Higher than 35% of US stocks
Higher than 30% of US stocks
- Return on equity
- —
- Return on assets
- —
- Dividend yield
- —
Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.
AMAN vs competitors
The nearest names by industry and size, scored by the same model — like for like.
This page is one stock. Monday covers all of them.
Computed off the Friday close and sent before the US open.
Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. AMAN appears on the weeks it earns a place.
Frequently asked questions about AMAN stock
How does Ticker Nerd's model rank AMAN?
As at 1 Aug 2026, Amanat Acquisition Corp. ranks 6 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Size (75 of 100).
What is the AMAN stock forecast for 2030?
No analyst covering Amanat Acquisition Corp. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for AMAN are extrapolating price history, which says nothing about the business.
What does Amanat Acquisition Corp. do?
Amanat Acquisition Corp is a special purpose acquisition company focused on identifying and completing a business combination in the healthcare and life sciences sectors. Structured as a blank check company, it raises capital from investors with the objective of merging with or acquiring an operating business, typically one seeking access to public capital markets.
About Amanat Acquisition Corp.
Amanat Acquisition Corp is a special purpose acquisition company focused on identifying and completing a business combination in the healthcare and life sciences sectors. Structured as a blank check company, it raises capital from investors with the objective of merging with or acquiring an operating business, typically one seeking access to public capital markets. Amanat Acquisition Corp targets companies across healthcare-related industries, including biopharmaceuticals, medical technology, diagnostics, healthcare services, and related platforms that align with the expertise of its management team. By providing a vehicle for private healthcare businesses to become publicly traded through a merger rather than a traditional initial public offering, Amanat Acquisition Corp plays a role in capital formation and corporate restructuring within the healthcare ecosystem. The company is incorporated as a Cayman Islands exempted company and is headquartered in Westfield, New Jersey, reflecting its focus on both global healthcare opportunities and access to major financial markets. Founded in 2026, it operates within the broader SPAC segment of the capital markets.
CEO Dr. Pavan Cheruvu M.D. · United States · https://amanatacquisition.com